A subsequent phase I study treated seven patients with metastatic solid tumors (four with breast cancer and three with melanoma) with an IV infusion of autologous c-Met-CAR-T cells modified by RNA electroporation (NCT03060356). The gene discussed is MET; the disease is melanoma.